ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimore

2d ago, source: Yahoo Finance

SOLANA BEACH, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device ...

ClearPoint Neuro Announces FDA Clearance of Prism Bone Anchor Accessory

5d ago, source:

Key Accessory to the ClearPoint Prism® Neuro Laser Therapy Will Enable Operating Room Placement of Laser Fibers The ...

ClearPoint Neuro Inc CLPT

2d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

ClearPoint Neuro receives US FDA 510(k) clearance for its Prism Bone Anchor Accessory

2d ago, source: Pharmabiz

ClearPoint Neuro, Inc, a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, announced it has received 510(k) clearance for its Prism Bone Anchor ...

Why ClearPoint Neuro (CLPT) Stock Might be a Great Pick

1mon ago, source: Zacks.com on MSN

One stock that might be an intriguing choice for investors right now is ClearPoint Neuro, Inc. CLPT. This is because this ...

ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR™ Stereotactic System

9d ago, source:

ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced it has initiated the ...

ClearPoint Neuro: Macro-Induced Multiple Compression

9d ago, source:

ClearPoint Neuro is expanding its product portfolio. Read why CLPT's fundamentals should remain solid even if the macro ...

ClearPoint Neuro Poised for Growth: Strong Buy Rating Justified Amidst Market Dip

12d ago, source:

Analyst Frank Takkinen from Lake Street reiterated a Buy rating on ClearPoint Neuro (CLPT – Research Report) and keeping the price target ...

ClearPoint Neuro Inc.

19d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...